申请人:Daly Kevin
公开号:US20090275570A1
公开(公告)日:2009-11-05
The invention relates to novel compounds of Formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds possess CHK1 kinase inhibitory activity, PDK1 inhibitory activity and Pak kinase inhibitory activity and are accordingly useful in the treatment and/or prophylaxis of cancer.
本发明涉及新的化合物(I)及其药物组成物和使用方法。这些新的化合物具有CHK1激酶抑制活性,PDK1抑制活性和Pak激酶抑制活性,因此在癌症的治疗和/或预防中有用。